Abevmy 400 mg/16 mL in Zimbabwe: Bevacizumab Sourcing Guide
Pharmaceutical procurement is rarely as simple as finding a medicine on a product list. For buyers in Zimbabwe, sourcing a specialty or oncology medicine can involve several additional considerations, including the exact product presentation, supplier information, documentation, import requirements and shipment coordination.
For buyers searching for Abevmy 400 mg/16 mL in Zimbabwe, it is useful to know both the brand name and the active pharmaceutical ingredient. Abevmy is a brand containing bevacizumab, while the 400 mg presentation contains 400 mg of bevacizumab in a 16 mL vial.
Sidmex Inovia currently lists Abevmy 400 mg Injection in its pharmaceutical portfolio and identifies Bevacizumab 400 mg as the active pharmaceutical ingredient.
What Is Abevmy 400 mg/16 mL?
Abevmy is a biological medicine containing the active substance bevacizumab. In the European Union, Abevmy is authorised as a biosimilar medicine to the reference medicine Avastin. It is used, in combination with other cancer treatments, for certain approved cancer indications.
The 400 mg presentation is:
Brand name: Abevmy Active pharmaceutical ingredient: Bevacizumab Strength: 400 mg/16 mL Concentration: 25 mg/mL Dosage form: Concentrate for solution for infusion
The official product information states that each 16 mL vial contains 400 mg of bevacizumab.
Abevmy is administered by intravenous infusion under the supervision of qualified healthcare professionals. Its approved indications, dosing and administration requirements depend on the applicable product information and regulatory jurisdiction. Buyers looking for related oncology products can also explore Sidmex Inovia's anti-cancer medicines portfolio.
Abevmy 400 mg Injection and Bevacizumab 400 mg
International pharmaceutical buyers may search for the same medicine in different ways.
A procurement team could search for:
Abevmy 400 mg Injection
Abevmy 400 mg/16 mL
Bevacizumab 400 mg
Bevacizumab 400 mg injection
Bevacizumab 400 mg/16 mL
Abevmy supplier in Zimbabwe
Bevacizumab supplier in Zimbabwe
This is why both terms should be clearly presented during a sourcing process.
The brand name, Abevmy, helps identify the specific marketed product, while bevacizumab identifies the active pharmaceutical ingredient. Including both in a sourcing enquiry can make communication more precise, especially when buyers are comparing products from different suppliers or markets.
Sourcing Abevmy 400 mg/16 mL in Zimbabwe
A buyer looking for Abevmy 400 mg in Zimbabwe may need more information than a product name alone.
A practical sourcing enquiry should clearly identify the product, presentation, active ingredient, required quantity and destination. For example:
Product: Abevmy 400 mg Injection Presentation: 400 mg/16 mL Active ingredient: Bevacizumab 400 mg Destination: Zimbabwe Quantity: As required by the buyer
Providing these details at the beginning can help reduce confusion and allow the supplier to evaluate the appropriate sourcing route.
For specialty medicines, procurement discussions may also involve manufacturer or marketed-by information, available documentation, batch and expiry information, packaging requirements and shipment conditions.
Sidmex Inovia's current product listing identifies Mylan Pharmaceuticals Pvt Ltd under its manufacturer/marketed-by information for the listed Abevmy 400 mg Injection.
Why the Exact Product Presentation Matters
In pharmaceutical procurement, small differences in presentation can make a significant difference to the accuracy of an enquiry.
Abevmy 400 mg/16 mL refers specifically to the 16 mL vial containing 400 mg of bevacizumab. The concentration is 25 mg/mL.
Therefore, a buyer should avoid sending an enquiry that only says "Abevmy" or "bevacizumab."
A clearer request such as "Abevmy 400 mg/16 mL, bevacizumab 400 mg, for Zimbabwe" provides much more useful information to a sourcing team.
This becomes particularly important when a procurement department is managing multiple strengths, presentations or brands of the same active pharmaceutical ingredient.
Pharmaceutical Import Requirements in Zimbabwe
Zimbabwe has a regulated framework for medicines, and pharmaceutical imports should be evaluated against the requirements applicable to the product and the responsible local importer.
The Medicines Control Authority of Zimbabwe (MCAZ) maintains official registers for approved medicines and states that its Evaluations and Registration Division is responsible for assessing the safety, efficacy and quality of medicines and issuing marketing authorizations.
MCAZ's online services also include processes relating to Import/Export of Registered Medicines and Section 75 applications.
For that reason, buyers should verify the current regulatory position before arranging an international shipment of Abevmy 400 mg/16 mL or another bevacizumab product.
A product appearing in an international supplier's catalogue should not automatically be interpreted as confirmation that it is registered for unrestricted sale or importation in Zimbabwe.
The local importer, healthcare organization or other responsible entity should establish the applicable requirements with MCAZ and ensure the necessary approvals and documentation are in place.
Documentation Should Be Considered Early
An international pharmaceutical purchase involves more than a quotation.
Depending on the transaction and regulatory requirements, a buyer may need to review information relating to:
Product identification — brand, active ingredient, strength and presentation.
Manufacturer information — relevant manufacturer or marketed-by details.
Product documentation — applicable quality and regulatory documents associated with the transaction.
Batch information — including available batch and expiry details where relevant.
Packaging information — ensuring the proposed presentation matches the purchasing requirement.
Shipping requirements — confirming that the logistics plan is appropriate for the product and destination.
For buyers searching for a bevacizumab supplier in Zimbabwe, having these discussions before finalising an order can make the procurement process more straightforward.
Considerations for Bevacizumab Supply
Because bevacizumab is a biological medicine, sourcing discussions should be handled with appropriate attention to product information, storage and transport requirements.
The current Abevmy product information specifies refrigerated storage at 2°C to 8°C and states that the medicine should not be frozen.
This is relevant when planning an international shipment.
The buyer and supplier should establish the applicable storage and transportation requirements before dispatch, rather than treating pharmaceutical logistics as a routine parcel shipment.
For an international pharmaceutical sourcing company, coordination between supplier, buyer, documentation and logistics is therefore an important part of the overall process.
Sourcing Bevacizumab 400 mg from India for Zimbabwe
India is a major pharmaceutical manufacturing and sourcing market, and international buyers frequently evaluate Indian suppliers when looking for pharmaceutical products.
For a Zimbabwean importer or procurement team searching for bevacizumab 400 mg from India, the sourcing process can begin with a clearly defined product requirement.
That requirement should include:
Abevmy 400 mg/16 mL Bevacizumab 400 mg Required quantity Destination: Zimbabwe
From there, the relevant supplier, documentation, commercial terms, regulatory requirements and logistics arrangements can be evaluated.
Sidmex Inovia currently lists Abevmy 400 mg Injection and identifies Bevacizumab 400 mg as its active pharmaceutical ingredient, providing an option for international buyers to submit a sourcing enquiry. Buyers can also learn more about Sidmex Inovia's specialty pharmaceutical export solutions.
What Zimbabwe Buyers Should Check Before Ordering
Before proceeding with a pharmaceutical sourcing request, buyers can benefit from reviewing the following points:
1. Confirm the exact product Make sure the requested brand, active ingredient, strength and presentation match the procurement requirement.
2. Confirm the regulatory pathway Check the requirements applicable in Zimbabwe and determine whether the product and proposed import route satisfy the relevant MCAZ requirements.
3. Review supplier information Establish the manufacturer or marketed-by information and confirm that the proposed product matches the requested specification.
4. Clarify documentation Discuss the documents required for the purchase, importation and shipment before the order is finalised.
5. Discuss storage and logistics For a refrigerated biological medicine such as Abevmy, transportation and storage conditions should be considered in advance.
6. Confirm commercial details Quantity, quotation, packaging, shipment terms and expected timelines should be agreed before dispatch.
This approach helps turn a product search into a more structured pharmaceutical procurement process.
Why Work With a Pharmaceutical Sourcing Partner?
A pharmaceutical sourcing partner should do more than locate a product.
For international buyers, particularly those sourcing specialty medicines, value can come from having one coordinated process covering product identification, supplier communication, documentation and export logistics.
For a Zimbabwe-focused requirement, the buyer may also need to coordinate with the local importer and confirm the destination-specific regulatory process.
Sidmex Inovia describes its approach around pharmaceutical sourcing, supplier evaluation, documentation, traceability and export-related coordination. Its quality-focused framework can be reviewed through its Quality Assurance Policy.
Frequently Asked Questions
Is Abevmy 400 mg the same as bevacizumab 400 mg?
Abevmy is a branded medicine containing bevacizumab as its active substance. The 400 mg presentation contains 400 mg of bevacizumab in a 16 mL vial.
What is Abevmy 400 mg/16 mL?
Abevmy 400 mg/16 mL is a presentation containing 400 mg of bevacizumab in 16 mL, equivalent to a concentration of 25 mg/mL. It is supplied as a concentrate for solution for infusion.
Can I source Abevmy 400 mg/16 mL for Zimbabwe?
Sidmex Inovia currently lists Abevmy 400 mg Injection in its pharmaceutical portfolio. Whether the product can be imported and supplied for a particular requirement in Zimbabwe depends on the applicable regulatory, importer and transaction requirements.
What should I include when requesting Bevacizumab 400 mg for Zimbabwe?
Include the brand name, active ingredient, strength, presentation, required quantity and destination. A clear example is: Abevmy 400 mg/16 mL, Bevacizumab 400 mg, destination Zimbabwe.
Does Abevmy need refrigerated storage?
The current European product information states that Abevmy should be stored in a refrigerator at 2°C to 8°C and should not be frozen. Applicable transportation requirements should be confirmed before shipment.
Is Abevmy approved in Zimbabwe?
Approval or registration in one jurisdiction does not establish approval in another. Zimbabwean buyers should verify the current status of the specific product and the applicable import requirements through MCAZ and the responsible local importer. MCAZ provides an official medicines register for regulatory verification.
Final Thoughts
For buyers searching for Abevmy 400 mg/16 mL in Zimbabwe, the most useful starting point is a precise product requirement.
Knowing both the brand name — Abevmy 400 mg Injection — and the active pharmaceutical ingredient — bevacizumab 400 mg — helps make the enquiry clearer. From there, the buyer can evaluate supplier information, documentation, regulatory requirements, storage conditions and international logistics before proceeding.
Sidmex Inovia lists Abevmy 400 mg Injection as part of its pharmaceutical portfolio. International buyers with a Zimbabwe requirement can use the product details above when preparing a sourcing enquiry.
Looking for Abevmy 400 mg/16 mL or bevacizumab 400 mg for a pharmaceutical requirement in Zimbabwe? Contact Sidmex Inovia with the required quantity, destination and product specifications to discuss a sourcing enquiry.
Comments